Vitamin D Metabolism and Action in Human Bone Marrow Stromal Cells
Open Access
- 1 January 2010
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 151 (1) , 14-22
Abstract
Vitamin D metabolites are important effectors of bone and mineral homeostasis. Extrarenal conversion of 25-hydroxyvitamin D (25OHD) to the biologically active form of vitamin D, 1α,25-dihydroxyvitamin D [1,25(OH)2D] is catalyzed in several cell types by the 1α-hydroxylase (CYP27B1), but little is known about the expression or regulation of CYP27B1 in human bones. We examined whether human bone marrow stromal cells (hMSCs, also known as mesenchymal stem cells) participate in vitamin D metabolism and whether vitamin D hydroxylases in hMSCs are influenced by the vitamin D status of the individual from whom the hMSCs were obtained. We also investigated the effects of vitamin D metabolites on osteoblast differentiation and the role of IGF-I in the regulation of CYP27B1. In a series of 27 subjects, vitamin D hydroxylases in hMSCs were expressed at different levels and were correlated with serum 25OHD, 1,25(OH)2D, and PTH. In vitro treatment with 25OHD up-regulated CYP27B1 and IGF-I in hMSCs; IGF-I also up-regulated CY27B1 expression and stimulated osteoblast differentiation. When hydroxylation of 25OHD was blocked by ketoconazole, a cytochrome P450 inhibitor, 25OHD was no longer able to induce CYP27B1 expression. In summary, these findings show that human bone marrow stromal cells have the molecular machinery both to metabolize and respond to vitamin D. We propose that circulating 25OHD, by virtue of its local conversion to 1,25(OH)2D catalyzed by basal CYP27B1 in hMSCs, amplifies vitamin D signaling through IGF-I up-regulation, which in turn induces CYP27B1 in a feed-forward mechanism to potentiate osteoblast differentiation initiated by IGF-I.Keywords
This publication has 54 references indexed in Scilit:
- Calcitonin, a Regulator of the 25-Hydroxyvitamin D3 1α-Hydroxylase GeneJournal of Biological Chemistry, 2009
- The skeleton as an intracrine organ for vitamin D metabolismMolecular Aspects of Medicine, 2008
- Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fracturesOsteoporosis International, 2008
- Age‐related intrinsic changes in human bone‐marrow‐derived mesenchymal stem cells and their differentiation to osteoblastsAging Cell, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Correlation of plain radiographic indices of the hip with quantitative bone mineral densityOsteoporosis International, 2007
- Evidence for auto/paracrine actions of vitamin D in bone: 1a‐hydroxylase expression and activity in human bone cellsThe FASEB Journal, 2006
- Resurrection of vitamin D deficiency and ricketsJournal of Clinical Investigation, 2006
- Differential biological effects of 1,25-dihydroxyVitamin D3 on melanoma cell lines in vitroThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Anabolic Therapy with Growth Hormone Accelerates Protein Gain in Surgical Patients Requiring Nutritional RehabilitationAnnals of Surgery, 1993